Current Insights on Percutaneous Coronary Intervention in Non-ST Elevation Acute Coronary Syndrome

Authors

  • Yudi Her Oktaviono Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga – Dr. Soetomo General Hospital, Surabaya, Indonesia http://orcid.org/0000-0002-2350-2789

DOI:

https://doi.org/10.21776/ub/hsj.2024.005.03.1

Keywords:

percutaneous coronary intervention, non-ST elevation acute coronary syndrome, complete revascularization, multivessel disease, coronary physiology, intravascular imaging

Abstract

Percutaneous coronary intervention (PCI) is a cornerstone in the management of non-ST elevation acute coronary syndrome (NSTE-ACS), offering significant improvements in patient outcomes. Risk stratification is critical in guiding the urgency and timing of PCI, with invasive strategies recommended for high-risk patients identified by clinical, electrocardiographic, biomarker assessments, or validated scores. Multivessel coronary artery disease is frequently observed in patients with NSTE-ACS and is correlated with an increased likelihood of recurrent myocardial infarction and mortality. Preferably during the index procedure, complete revascularization should be considered in patients with stable hemodynamics. Functional invasive evaluation, including fractional flow reserve, may help assess the hemodynamic significance of coronary lesions and decide whether a non-culprit stenosed vessel prompts revascularization. Intravascular imaging techniques with optical coherence tomography and intravascular ultrasound are essential for evaluating lesion characteristics, optimizing stent deployment, and enhancing the precision of PCI. Overall, a personalized interventional approach in NSTE-ACS incorporating risk stratification, timely intervention, careful consideration of multivessel disease, and advanced diagnostic modalities is paramount in enhancing patient prognosis and minimizing recurrent ischemic events.

...

References

Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2023;44(38):3720-3826.

Members WC, Lawton JS, Tamis-Holland JE, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(2):e21-e129.

Elgendy IY, Mahmoud AN, Wen X, Bavry AA. Meta-analysis of randomized trials of long-term all-cause mortality in patients with non–ST-elevation acute coronary syndrome managed with routine invasive versus selective invasive strategies. Am J Cardiol. 2017;119(4):560-564.

Fox KAA, Poole-Wilson PA, Henderson RA, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. The Lancet. 2002;360(9335):743-751.

Mehta SR, Cannon CP, Fox KAA, et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA. 2005;293(23):2908-2917.

Mehta SR, Granger CB, Boden WE, et al. Early versus delayed invasive intervention in acute coronary syndromes. New England Journal of Medicine. 2009;360(21):2165-2175.

Kofoed KF, Kelbæk H, Hansen PR, et al. Early versus standard care invasive examination and treatment of patients with non-ST-segment elevation acute coronary syndrome: VERDICT randomized controlled trial. Circulation. 2018;138(24):2741-2750.

Sardella G, Lucisano L, Garbo R, et al. Single-staged compared with multi-staged PCI in multivessel NSTEMI patients: the SMILE trial. J Am Coll Cardiol. 2016;67(3):264-272.

Elscot JJ, Kakar H, Scarparo P, et al. Timing of complete multivessel revascularization in patients presenting with non-ST-segment elevation acute coronary syndrome. Cardiovascular Interventions. 2024;17(6):771-782.

Thiele H, Akin I, Sandri M, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. New England Journal of Medicine. 2017;377(25):2419-2432.

Sels JWEM, Tonino PAL, Siebert U, et al. Fractional flow reserve in unstable Angina and non–ST-segment elevation myocardial infarction: experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. JACC Cardiovasc Interv. 2011;4(11):1183-1189.

Layland J, Oldroyd KG, Curzen N, et al. Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS–NSTEMI randomized trial. Eur Heart J. 2015;36(2):100-111.

Meneveau N, Ecarnot F, Souteyrand G, et al. Does optical coherence tomography optimize results of stenting? Rationale and study design. Am Heart J. 2014;168(2):175-181.

Gao XF, Ge Z, Kong XQ, et al. 3-year outcomes of the ULTIMATE trial comparing intravascular ultrasound versus angiography-guided drug-eluting stent implantation. Cardiovascular Interventions. 2021;14(3):247-257.

Berg ES, Tegn NK, Abdelnoor M, et al. Long-Term outcomes of invasive vs conservative strategies for older patients with Non–ST-Segment elevation acute coronary syndromes. J Am Coll Cardiol. 2023;82(21):2021-2030.

Downloads

Published

2024-07-30